Head cancer research and nanomedicine laboratoryDepartment of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Israel
52: Anti-HER-2 Chimeric Antigen Receptor T (CAR-T) Cells Immunotherapy for Pancreatic Cancer: An Innovative Surgically Derived Tumor Spheroid Model
Saturday, March 23, 20248:22am – 8:32am ET